Download PDF
Nervenheilkunde 2004; 23(08): 457-464
DOI: 10.1055/s-0038-1626411
Original- und Übersichtsarbeiten - Original and Review Articles
Schattauer GmbH

Kardiale Beteiligung bei hereditären und erworbenen Muskelerkrankungen

Cardiac involvement in hereditary and acquired muscle diseases
S. Neudecker
1   Klinik und Poliklinik für Neurologie, Martin-Luther-Universität Halle-Wittenberg
,
S. Zierz
1   Klinik und Poliklinik für Neurologie, Martin-Luther-Universität Halle-Wittenberg
› Author Affiliations
Further Information

Publication History

Publication Date:
19 January 2018 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die Skelettmuskulatur und der Herzmuskel sind zwei anatomisch eindeutig voneinander zu unterscheidende Gewebe, die dennoch verschiedene Gemeinsamkeiten aufweisen. Erkrankungen mit primärem Befall der Skelettmuskulatur können deshalb auch zur Manifestation kardialer Symptome führen und umgekehrt. Obgleich bei Myopathien häufig Paresen und Atrophien bzw. Myalgien im Vordergrund der Beschwerden stehen, können kardiale Symptome einen erheblichen Einfluss auf die Lebensqualität und -erwartung besitzen und in Einzelfällen das klinische Bild dominieren. In der vorliegenden Arbeit werden diejenigen hereditären und erworbenen Muskelkrankheiten aufgeführt, bei denen eine Herzbeteiligung bekannt ist.

Summary

Although the skeletal muscle and the heart are two anatomical distinct tissues, they have several similarities. Primary myogenic disorders may have a cardiac involvement and vice versa. Weakness, muscular atrophy and myalgias are the most important symptoms in myopathies. However, cardiac involvement in myopathies may have a wide influence on quality of life and on life expectancy. In this paper hereditary and acquired muscle diseases with cardiac involvement are presented.

Schlüsselwörter

Myopathien - hereditär - erworben - Herzbeteiligung

Keywords

Myopathies - hereditary - acquired - cardiac involvement - heart
 

  • Literatur

  • 1 Amit R, Bashan N, Abarbanel JM, Shapira Y, Sofer S, Moses S. Fatal familial infantile glycogen storage disease: multisystem phosphofructokinase deficiency. Muscle Nerve 1992; 15: 455-8.
    CrossrefPubMedGoogle Scholar
  • 2 Anan R, Nakagawa M, Miyata M, Higuchi I, Nakao S, Suehara M, Osame M, Tanaka H. Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. Circulation 1995; 91: 955-61.
    Google Scholar
  • 3 Andelfinger G, Tapper AR, Welch RC, Vanoye CG, George Jr AL, Benson DW. KCNJ2 mutation results in Andersen syndrome with sexspecific cardiac and skeletal muscle phenotypes. Am J Hum Genet 2002; 71: 663-8.
    CrossrefPubMedGoogle Scholar
  • 4 Ashwal S, Peckham N. Myoadenylate deaminase deficiency in children. Pediatr Neurol 1985; 01: 185-91.
    CrossrefPubMedGoogle Scholar
  • 5 Askari AD, Huettner TL. Cardiac abnormalities in polymyositis/dermatomyositis. Sem Arthr Rheumat 1982; 12: 208-19.
    Google Scholar
  • 6 Ationu A, Humphries A. The feasibility of replacement therapy for inherited disorder of glycolysis: triosephosphate isomerase deficiency. Int J Mol Med 1998; 02: 701-4.
    Google Scholar
  • 7 Banwell BL, Becker LE, Jay V, Taylor GP, Vajsar J. Cardiac manifestations of congenital fiber-type disproportion myopathy. J Child Neurol 1999; 14: 83-7.
    CrossrefPubMedGoogle Scholar
  • 8 Barth PG, Wanders RJ, Vreken P, Janssen EA, Lam J. Baas F X-linked cardioskeletal myopathy and neutropenia (Barth syndrome) (MIM 302060). J Inherit Metab Dis 1999; 22: 555-67.
    CrossrefPubMedGoogle Scholar
  • 9 Bonnet D, Martin D, Pascale De Lonlay, Villain E, Jouvet P, Rabier D, Brivet M, Saudubray JM. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation 1999; 100: 2248-53.
    CrossrefPubMedGoogle Scholar
  • 10 Boriani G, Gallina M, Merlini L, Bonne G, Toniolo D, Amati S, Biffi M, Martignani C, Frabetti L, Bonvincini M, Rapezzi C, Branzi A. Clinical relevance of atrial fibrillation/flutter, stroke, pacemaker implant, and heart failure in Emery-Dreifuss muscular dystrophy. A long term study. Stroke 2003; 34: 901-8.
    PubMedGoogle Scholar
  • 11 Brodsky GL, Muntoni F, Miocic S, Sinagra G, Sewry C, Mestroni L. Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation 2000; 101: 473-6.
    CrossrefPubMedGoogle Scholar
  • 12 Brottier L, Coste P, Combe C, Bruchere C, Bonnet J, Bricaud H. Cardiac complications of dermatopolymyositis. Apropos of 56 cases. Arch Mal Coeur Vaiss 1987; 80: 1133-8.
    PubMedGoogle Scholar
  • 13 Buchpiguel CA, Roizemblatt S, Pastor EH, Hironaka FH, Cossermelli W. Cardiac and skeletal muscle scintigraphy in dermatoand polymyositis: clinical implications. Eur J Nucl Med 1996; 23: 199-203.
    CrossrefPubMedGoogle Scholar
  • 14 Buckley AE, Dean J, Mahy IR. Cardiac involvement in Emery-Dreifuss muscular dystrophy: a case series. Heart 1999; 82: 105-8.
    CrossrefPubMedGoogle Scholar
  • 15 Bulkley BH, Hutchins GM. Pompe’s disease presenting as hypertrophic myocardiopathy with Wolff-Parkinson-White syndrome. Am Heart J 1978; 96: 246-52.
    CrossrefPubMedGoogle Scholar
  • 16 Buruma OJ, Schipperheyn JJ, Bots GT. Heart muscle disease in familial hypokalaemic periodic paralysis. Acta Neurol Scand 1981; 64: 12-21.
    PubMedGoogle Scholar
  • 17 Bushby K, Muntoni F, Bourke JP. The management of cardiac involvement in muscular dystrophy and myotonic dystrophy: 107th ENMC international workshop. Neuromusc Disord 2003; 13: 166-72.
    CrossrefPubMedGoogle Scholar
  • 18 Caforio ALP, Rossi B, Risaliti R, Siciliano G, Marchetti A, Corrado A, Crea F, Mariani M, Muratorio C. Type 1 fiber abnormalities in skeletal muscle of patients with hypertrophic and dilated cardiomyopathy: Evidence of subclinical myogenic myopathy. J Am Coll Cardiol 1989; 14: 1464-73.
    CrossrefPubMedGoogle Scholar
  • 19 Corrado G, Lissoni A, Beretta S, Terenghi L, Tadeo G, Foglia-Manzillo G, Tagliagambe LM, Spata M, Santarone M. Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 2002; 89: 838-41.
    CrossrefPubMedGoogle Scholar
  • 20 Dalakas MC. Polymyositis, dermatomyositis, and inclusion-body myositis. New Engl J Med 1991; 325: 1487-98.
    PubMedGoogle Scholar
  • 21 Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W, Schneider C, Koch MC, Beilman GJ, Harrison AR, Dalton JC, Ranum LP. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 2003; 60: 657-64.
    CrossrefPubMedGoogle Scholar
  • 22 de Visser M. The heart in Becker muscular dystrophy, facioscapulohumeral dystrophy, and Bethlem myopathy. Muscle Nerve 1992; 15: 591-6.
    CrossrefPubMedGoogle Scholar
  • 23 Dobkin BH, Verity MA. Familial neuromuscular disease with type 1 fiber hypoplasia, tubular aggregates, cardiomyopathy, and myasthenic features. Neurology 1978; 28: 1135-40.
    CrossrefPubMedGoogle Scholar
  • 24 Durbeej M, Campbell KP. Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr Opin Genet Dev 2002; 12: 349-61.
    CrossrefPubMedGoogle Scholar
  • 25 Emery AEH. Abnormalities of the electrocardiogram in hereditary myopathies. J Med Genet 1972; 09: 8-12.
    CrossrefPubMedGoogle Scholar
  • 26 Emery AEH. Emery-Dreifuss muscular dystrophy – a 40 year retrospective. Neuromusc Disord 2000; 10: 228-32.
    CrossrefPubMedGoogle Scholar
  • 27 Fanin M, Melacini P, Boito C, Pegoraro E, Angelini C. LGMD2E patients risk developing dilated cardiomyopathy. Neuromusc Disord 2003; 13: 303-9.
    CrossrefPubMedGoogle Scholar
  • 28 Felice KJ, North WA. Inclusion body myositis in Connecticut. Observations in 35 patients during a 8-year period. Medicine 2001; 80: 320-7.
    PubMedGoogle Scholar
  • 29 Ferreiro A, Estournet B, Chateau D, Romero NB, Laroche C, Odent S, Toutain A, Cabello A, Fontan D, dos Santos HG, Haenggeli CA, Bertini E, Urtibeea JA, Guicheney P, Fardeau M. Multi-Minicore disease searching for boundaries: phenotype analysis of 38 cases. Ann Neurol 2000; 48: 745-57.
    CrossrefPubMedGoogle Scholar
  • 30 Finsterer J, Stöllberger C, Blazek G, Spahits E. Cardiac involvement in myotonic dystrophy, Becker muscular dystrophy and mitochondrial myopathy: A five year follow-up. Can J Cardiol 2001; 17: 1061-9.
    PubMedGoogle Scholar
  • 31 Finsterer J, Gharehbaghi-Schnell E, Stöllberger C, Fheodoroff K, Seiser A. Relation of cardiac abnormalities and CTG-repeat size in myotonic dystrophy. Clin Genet 2001; 59: 350-5.
    PubMedGoogle Scholar
  • 32 Finsterer J, Stollberger C, Michaela J. Familial left ventricular hypertrabeculation in two blind brothers. Cardiovasc Pathol 2002; 11: 146-8.
    CrossrefPubMedGoogle Scholar
  • 33 Finsterer J, Stöllberger C. The heart in human dystrophinopathies. Cardiology 2003; 99: 1-19.
    CrossrefPubMedGoogle Scholar
  • 34 Fragola PV, Luzi M, Calo L, Antonini G, Borzi M, Frongillo D, Cannata D. Cardiac involvement in myotonic dystrophy. Am J Cardiol 1994; 74: 1070-2.
    CrossrefPubMedGoogle Scholar
  • 35 Francesconi M, Auff E. Cardiac arrhythmias and the adult form of type II glycogenosis. N Engl J Med 1982; 306: 937-8.
    CrossrefPubMedGoogle Scholar
  • 36 Funakoshi M, Tsuchiya Y, Arahata K. Emerin and cardiomyopathy in Emery-Dreifuss muscular dystrophy. Neuromusc Disord 1999; 09: 108-14.
    CrossrefPubMedGoogle Scholar
  • 37 Goldfarb LG, Vicart P, Goebel HH, Dalakas MC. Desmin myopathy. Brain 2004; 127: 723-34.
    CrossrefPubMedGoogle Scholar
  • 38 Gonzalez-Lopez L, Gamez-Nava JI, Sanchez L, Rosas E, Suarez-Almazor M, Cardona-Munoz C, Ramos-Remus C. Cardiac manifestations in dermato-polymyositis. Clin Exp Rheumatol 1996; 14: 373-9.
    PubMedGoogle Scholar
  • 39 Grain L, Cortina-Borja M, Forfar C, Hilton-Jones D, Hopkin J, Burch M. Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls. Neuromuscul Disord 2001; 11: 186-91.
    CrossrefPubMedGoogle Scholar
  • 40 Hayashi Y, Ikeda U, Kojo T, Nishinaga M, Miyashita H, Kuroda T, Inoue K, Nishizawa M, Shimada K. Cardiac abnormalities and CTG trinucleotid repeats in myotonic dystrophy. Am Heart J 1997; 134: 292-7.
    CrossrefPubMedGoogle Scholar
  • 41 Hoogerwaard EM, de Voogt WG, Wilde AAM, van der Wouw PA, Bakker E, van Ommen GJB, de Visser M. Evolution of cardiac abnormalities in Becker muscular dystrophy over a 13-year period. J Neurol 1997; 244: 657-63.
    CrossrefPubMedGoogle Scholar
  • 42 Hoogerwaard EM, van der Wouw PA, Wilde AA, Bakker E, Ippel PF, Oosterwijk JC, Majoor-Krakauer DF, van Essen AJ, Leschot NJ, de Visser M. Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord 1999; 09: 347-51.
    CrossrefPubMedGoogle Scholar
  • 43 Igarashi H, Momoi MY, Yamagata T, Shiraishi H, Eguchi I. Hypertrophic cardiomyopathy in congenital myotonic dystrophy. Pediatr Neurol 1998; 18: 366-9.
    CrossrefPubMedGoogle Scholar
  • 44 Ishikawa Y, Bach JR, Ishikawa Y, Minami R. A management trial for Duchenne cardiomyopathy. Am J Phys Med Rehabil 1995; 74: 345-50.
    PubMedGoogle Scholar
  • 45 Jones KJ, Morgan G, Johnston H, Tobias V, Ouvrier RA, Wilkinson I, North KN. The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review. J Med Genet 2001; 38: 649-57.
    CrossrefPubMedGoogle Scholar
  • 46 Kaneda D, Sugie K, Yamamoto A, Matsumoto H, Kato T, Nonaka I, Nishino I. A novel form of autophagic vacuolar myopathy with late-onset and multiorgan involvement. Neurology 2003; 61: 128-31.
    CrossrefPubMedGoogle Scholar
  • 47 Kearns TP, Sayre GP. Retinitis pigmentosa, external ophthalmophegia, and complete heart block: unusual syndrome with histologic study in one of two cases. Am Arch Opthalmol 1958; 60: 280-9.
    Google Scholar
  • 48 Koul RL, Chand RP, Chacko A, Ali M, Brown KM, Bushnarmuth SR, Escolar DM, Stephan DA. Severe autosomal recessive rippling muscle disease. Muscle Nerve 2001; 24: 1542-7.
    CrossrefPubMedGoogle Scholar
  • 49 Krasnianski M, Neudecker S, Deschauer M, Zierz S. Klinisches Spektrum der Gliedergürtelmuskeldystrophie Typ 2I bei Mutation im “Fuktutin-related Protein”. Nervenarzt. 2004 DOI: 10.1007/s00115-004-1726-3.
    PubMedGoogle Scholar
  • 50 Laforet P, de Toma C, Eymard B, Becane HM, Jeanpierre M, Fardeau M, Duboc D. Cardiac involvement in genetically confirmed facioscapulohumeral muscular dystrophy. Neurology 1998; 51: 1454-6.
    CrossrefPubMedGoogle Scholar
  • 51 Lev D, Nissenkorn A, Leshinsky-Silver E, Sadeh M, Zeharia A, Garty BZ, Blieden L, Barash V, Lerman-Sagie T. Clinical Presentations of Mitochondrial Cardiomyopathies. Pediatr Cardiol. 2004 DOI: 10.1007/s00246-003-0490-7.
    PubMedGoogle Scholar
  • 52 Loh E, Rebbeck TR, Mahoney PD, DeNofrio D, Swain JL, Holmes EW. Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure. Circulation 1999; 99: 1422-5.
    CrossrefPubMedGoogle Scholar
  • 53 Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ. Inclusion body myositis. Observations in 40 patients. Brain 1989; 112: 727-47.
    PubMedGoogle Scholar
  • 54 Markesbery WR, Griggs RC, Leach RP, Lapham LW. Late onset hereditary distal myopathy. Neurology 1974; 24: 127-34.
    CrossrefPubMedGoogle Scholar
  • 55 Melberg A, Oldfors A, Blomstrom-Lundqvist C, Stalberg E, Carlsson B, Larsson E, Lidell C, Eeg-Olofsson KE, Wikstrom G, Henriksson KG, Dahl N. Autosomal dominant myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy linked to chromosome 10q. Ann Neurol 1999; 46: 684-92.
    CrossrefPubMedGoogle Scholar
  • 56 Mercuri E, Brockongton M, Straub V, QuijanoRoy S, Yuva Y, Herrmann R, Brown SC, Torelli S, Dubowitz V, Blake DJ, Romero NB, Estournet B, Sewry CA, Guicheney P, Voit T, Muntoni F. Phenotypic spectrum associated with mutations in the fuktutin-related protein gene. Ann Neurol 2003; 53: 537-42.
    CrossrefPubMedGoogle Scholar
  • 57 Messina DN, Speer MC, Vance MAPericak, McNally EM. Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23. Am J Hum Genet 1997; 61: 909-17.
    CrossrefPubMedGoogle Scholar
  • 58 Mimaki M, Ikota A, Sato A, Komaki H, Akanuma J, Nonaka I, Goto Y. A double mutation (G11778A and G12192A) in mitochondrial DNA associated with Leber’s hereditary optic neuropathy and cardiomyopathy. J Hum Genet 2003; 48: 47-50.
    CrossrefPubMedGoogle Scholar
  • 59 Muntoni F. Cardiomyopathy in muscular dystrophies. Curr Opin Neurol 2003; 16: 577-83.
    CrossrefPubMedGoogle Scholar
  • 60 Moses SW, Wanderman KL, Myroz A, Frydman M. Cardiac involvement in glycogen storage disease type III. Eur J Pediatr 1989; 148: 764-6.
    CrossrefPubMedGoogle Scholar
  • 61 Müller-Höcker J, Schäfer S, Mendel B, Lochmüller H, Pongratz D. Nemaline cardiomyopathy in a young adult: an ultraimmu-nohistochemical study and review of the literature. Ultrastruct Pathol 2000; 24: 407-16.
    CrossrefPubMedGoogle Scholar
  • 62 Nagamachi S, Inoue K, Jinnouchi S, Hoshi H, Ono S, Ohnisi T, Futami S, Watanabe K, Hayashi T. Cardiac involvement of progressive muscular dystrophy (Becker type, Limb-girdle type and Fukuyama type) valuated by adionuclide method. Ann Nucl Med 1994; 08: 71-4.
    CrossrefPubMedGoogle Scholar
  • 63 Nicholls DP, Campbell NP, Stevenson HP, Patterson VH. Angina in McArdle’s disease. Heart 1996; 76: 372-3.
    CrossrefPubMedGoogle Scholar
  • 64 Nolan MA, Jones ODH, Pedersen RL, Johnston HM. Cardiac assessment in childhood carriers of Duchenne and Becker muscular dystrophies. Neuromusc Disord 2003; 13: 129-32.
    CrossrefPubMedGoogle Scholar
  • 65 Noori S, Acherman R, Siassi B, Luna C, Ebrahimi M, Pavlova Z, Ramanathan R. A rare presentation of Pompe disease with massive hypertrophic cardiomyopathy at birth. J Perinat Med 2002; 30: 517-21.
    PubMedGoogle Scholar
  • 66 Okajima Y, Tanabe Y, Takayanagi M, Aotsuka H. A follow up study of myocardial involvement in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). Heart 1998; 80: 292-5.
    CrossrefPubMedGoogle Scholar
  • 67 Ozawa M, Goto Y, Sakuta R, Tanno Y, Tsuji S, Nonaka I. The 8,344 mutation in mitochondrial DNA: a comparison between the proportion of mutant DNA and clinico-pathologic findings. Neuromuscul Disord 1995; 05: 483-8.
    CrossrefPubMedGoogle Scholar
  • 68 Pepe G, Bertini E, Bonaldo P, Bushby K, Giusti B, de Visser M, Guicheney P, Lattanzi G, Merlini L, Muntoni F, Nishino I, Nonaka I, Ben Yaou R, Sabatelli P, Sewry C, Topaloglu H, van der Kooi A. Bethlem myopathy and Ullrich scleroatonic muscular dystrophy: 100th ENMC international workshop. Neuromusc Disord 2002; 12: 984-93.
    CrossrefPubMedGoogle Scholar
  • 69 Philips MF, Harper PS. Cardiac disease in myotonic dystrophy. Cardiovasc Res 1997; 33: 13-22.
    CrossrefPubMedGoogle Scholar
  • 70 Politano L, Nigro V, Passamo L, Petretta V, Comi LI, Papparella S, Nigro Ge, Rambaldi PF, Raia P, Pini A, Mora M, Giugliano MAM, Esposito MG, Nogro G. Evaluation of cardiac and respiratory involvement in sarcoglycanopathies. Neuromusc Disord 2001; 11: 178-85.
    CrossrefPubMedGoogle Scholar
  • 71 Poppe M, Cree L, Bourke J, Eagle M, Anderson LVB, Birchall D, Brockington M, Buddles M, Busby M, Muntoni F, Wills A, Bushby K. The phenotype of limb-girdle muscular dystrophy type 2I. Neurology 2003; 60: 1246-51.
    CrossrefPubMedGoogle Scholar
  • 72 Rampoldi L, Danek A, Monaco AP. Clinical features and molecular bases of neuroacanthocytosis. J Mol Med 2002; 80: 475-91.
    CrossrefPubMedGoogle Scholar
  • 73 Regalado JJ, Rodriguez MM, Ferrer PL. Infantile hypertrophic cardiomyopathy of glycogenosis type IX: isolated cardiac phosphorylase kinase deficiency. Pediatr Cardiol 1999; 20: 304-7.
    CrossrefPubMedGoogle Scholar
  • 74 Saudubray JM, Martin D, de Lonlay P, Touati G, Poggi-Travert F, Bonnet D, Jouvet P, Boutron M, Slama A, Vianey-Saban C, Bonnefont JP, Rabier D, Kamoun P, Brivet M. Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis 1999; 22: 488-502.
    PubMedGoogle Scholar
  • 75 Selcen D, Engel AE. Mutations in myotilin cause myofibrillar myopathy. Neurology 2004; 62: 1363-71.
    CrossrefPubMedGoogle Scholar
  • 76 Servidei S, Riepe RE, Langston C, Tani LY, Bricker JT, Crisp-Lindgren N, Travers H, Armstrong D, DiMauro S. Severe cardiopathy in branching enzyme deficiency. J Pediatr 1987; 111: 51-6.
    CrossrefPubMedGoogle Scholar
  • 77 Servidei S. Mitochondrial encephalomyopathies: gene mutation. Neuromusc Disord 2004; 14: 107-16.
    CrossrefPubMedGoogle Scholar
  • 78 Shuaib A, Paasuke RT, Brownell AKW. Central core disease. Clinical features in 13 patients. Medicine 1987; 66: 389-96.
    CrossrefPubMedGoogle Scholar
  • 79 Skyllouriotis ML, Marx M, Bittner RE, Skyllouriotis P, Gross M, Wimmer M. Myoadenylate deaminase deficiency, hypertrophic cardiomyopathy and gigantism syndrome. Pediatr Neurol 1997; 17: 61-6.
    CrossrefPubMedGoogle Scholar
  • 80 Stöllberger C, Finsterer J, Bittner RE. Angina for 14 years. Lancet 1997; 349: 1292.
    CrossrefPubMedGoogle Scholar
  • 81 Sugie K, Yamamoto A, Murayama K, Oh SJ, Takahashi M, Mora M, Riggs JE, Colomer J, Iturriaga C, Meloni A, Lamperti C, Saitoh S, Byrne E, DiMauro S, Nonaka I, Hirano M, Nishino I. Clinicopathological features of genetically confirmed Danon disease. Neurology 2002; 58: 1773-8.
    CrossrefPubMedGoogle Scholar
  • 82 Taylor AJ, Wortham DC, Burge JR, Rogan KM. The heart in polymyositis: a prospective evaluation of 26 patients. Clin Cardiol 1993; 16: 802-8.
    CrossrefPubMedGoogle Scholar
  • 83 Urtizberea JA, Duboc D, Schwartz K, Bonne G. Dilated cardiomyopathy and related cardiac disorders in muscular dystrophy. In: Emery AEH. (ed.). The muscular dystrophies. Oxford: Oxford University Press; 2001: 202-22.
    Google Scholar
  • 84 van der Kooi AJ, Ledderhof TM, de Voogt WG, Res JCJ, Bouwsma G, Troost D, Busch HFM, Becker AE, de Visser M. A newly recognized autosomal dominant limb girdle muscular dystrophy with cardiac involvement. Ann Neurol 1996; 39: 636-42.
    CrossrefPubMedGoogle Scholar
  • 85 Voit T, Krogmann O, Lenard HG, Neuen-Jacob E, Wechsler W, Goebel HH, Rahlf G, Lindinger A, Nienaber C. Emery-Dreifuss muscular dystrophy: disease spectrum and differential diagnosis. Neuropediatrics 1988; 19: 62-71.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 86 von zur Mühlen F, Klass C, Kreuzer H, Mall G, Giese A, Reimers CD. Cardiac involvement in proximal myotonic myopathy. Heart 1998; 79: 619-21.
    CrossrefPubMedGoogle Scholar
  • 87 Williams MJ, Hammond-Tooke GD, Restieaux NJ. Hypokalaemic periodic paralysis with cardiac arrhythmia and prolonged QT interval. Aust N Z J Med 1995; 25: 549.
    CrossrefPubMedGoogle Scholar
  • 88 Zatz M, de Paula F, Starling A, Vainzof M. The 10 autosomal rezessive limb-girdle muscular dystrophies. Neuromusc Disord 2003; 13: 532-44.
    CrossrefPubMedGoogle Scholar